Skip to main content
Consun Pharmaceutical Group Limited logo

Consun Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1681 HKEX Manufacturing
Open in API
Filings indexed 849 across all filing types
Latest filing 2025-11-21 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 1681

About Consun Pharmaceutical Group Limited

http://www.chinaconsun.com

Consun Pharmaceutical Group Limited is a modern pharmaceutical enterprise engaged in the integrated research, development, manufacturing, and marketing of pharmaceutical products. The company's core business is segmented into Modern Chinese Medicines (MCM) and Medical Contrast Medium products. The MCM portfolio targets major therapeutic areas, including chronic renal diseases (featuring products like Uremic Clearance Granules), liver and gallbladder conditions, and orthopedic trauma. In the medical imaging field, Consun supplies contrast agents such as Gadopentetate Dimeglumine Injection for magnetic resonance imaging (MRI) and Iopamidol Injection for angiography and neuro-radiology. The enterprise focuses on combining the modernization of Chinese medicine with advanced diagnostic solutions.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a 'Next Day Disclosure Return' (Form FF305) filed with the Stock Exchange of Hong Kong. It details specific share repurchase activities by Consun Pharmaceutical Group Limited, including the number of shares repurchased, the price paid, and confirmation of compliance with listing rules. This document type is specifically used for reporting share buybacks and changes in issued shares, which falls under the 'Transaction in Own Shares' category.
2025-11-21 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a 'Next Day Disclosure Return' (Form FF305) filed with the Stock Exchange of Hong Kong. It details specific share repurchase activities by Consun Pharmaceutical Group Limited, including the number of shares repurchased, the price paid, and confirmation of compliance with listing rules. This document type is specifically designed for reporting share buybacks and changes in issued shares, which falls under the 'Transaction in Own Shares' category.
2025-11-20 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a 'Next Day Disclosure Return' (Form FF305) filed with the Stock Exchange of Hong Kong. It details the company's share repurchase activity (buying back its own shares) on a specific date. According to the filing definitions, reports of a company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2025-11-19 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a 'Next Day Disclosure Return' (Form FF305) filed with the Stock Exchange of Hong Kong. It details specific share repurchase activities (buybacks) conducted by Consun Pharmaceutical Group Limited on 18 November 2025. According to the filing definitions, documents reporting a company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2025-11-18 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a 'Next Day Disclosure Return' (Form FF305) filed with the Stock Exchange of Hong Kong. It details specific share repurchase transactions (buybacks) conducted by Consun Pharmaceutical Group Limited. According to the filing definitions, reports of a company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2025-11-17 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a 'Next Day Disclosure Return' (Form FF305) filed with the Hong Kong Stock Exchange. It details specific share repurchases made by Consun Pharmaceutical Group Limited on 14 November 2025. This document type is specifically designed for reporting share buybacks and changes in issued shares, which falls under the 'Transaction in Own Shares' category.
2025-11-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.